$ALST Speculative PPE Covid Play With Bullish Pattern Posture
ALST
is thin, but promising from the standpoint of a base of clear support, a broken downtrend line, and a serial RSI divergence sequence following a bullish oversold RSI reading at the initial downside price extreme that started the basing process. --------------------------
ALST (Allstar Health Brands Inc.) is a Nevada Corporation established in 2017, and headquartered in Miami, Florida.
AllStar is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select products, including medical devices, nutritional supplements, over the counter remedies and medicines across the Americas and Europe. AllStar's goal is to bring additional products to the market and provide new, innovative options for better health and well-being.
The company focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas. AllStar holds the “Tapout” brand license to sell globally branded nutraceutical products, including pain relief sprays and wipes. It has partnership with World Wide Entertainment (WWE) to market and sell their line of “Tapout” branded nutraceutical products.
In addition, according to recent materials, the company has begun to focus sharply on front-line products. AllStar is now working with qualified overseas suppliers to provide products such as PPE (Personal Protective Equipment) as demand is expected to increase sharply with the gradual re-opening of the economy.
AllStar has already begun distributing protective masks and is expanding its product line to include gowns and gloves to established businesses and various types of medical clinics such as optometrists, long-term care facilities and hospitals. As such, first-order deliveries of the Covid-19 IgG/IgM antibody rapid test have already been made to a Distributor for the Caribbean and Latin American region, and US delivery is in process. In addition, KN 95 protective masks, - the functional equivalent of the N 95 mask - have been sold already in Canada and AllStar is also working to deliver the much-needed masks to other countries.
Key Points:
• ALST booked a sharp leap in sales in May, with a sudden influx of over $100K in revenues as the company ramps up commercial-stage operations in the Covid-19 space
• ALST is making real money, with trailing revs already coming in, an apparently accelerating as its antibody testing and PPE offerings gain traction
• ALST recently stated that management believes it could see as much as $1 million in sales in 2020.
• ALST is also seeing some basing activity on the chart, with a broken downtrend line now as the salient feature, along with gradually ramping liquidity and trading volume
• ALST just got current with the OTC
• ALST is coming off an RSI trough under 40, pointing to a massively oversold stock now heading back the other way.
Conclusion
ALST just got fully current with OTC markets. This story is just starting to hit the radar for traders and investors searching for opportunities in the PPE and antibody testing space.
The company just booked $100k in sales for COVID-19 products over a month of aggressive activity in May, and there’s no signs of decline so far in June according to the company. Given this activity, and the stock’s action – which shows both positive technical signals in terms of trend as well as increasing trading activity and liquidity – one might reasonably anticipate some coming opportunities as it becomes more visible as a play in the space.
This is a company, by all available information, that is predicated on aggressive sales and marketing efforts. And, as outlined by management in recent communications, it is actively engaged in opening doors to PPE and antibody testing kit sales in South America as the Covid-19 pandemic health crisis erupts in the southern hemisphere during their winter and cold & flu season.